Global Blood Therapeutics (GBT) News Today → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free GBT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmex GBT to Acquire CWT for $570 Millionskift.com - March 25 at 9:25 AMHow Dr. Ted Love, a cardiologist turned biotech executive, sold his sickle cell company to Pfizer for $5.4Bmsn.com - March 22 at 4:27 PMHow Dr. Ted Love Sold Sickle Cell Company To Pfizer For $5.4 Billionforbes.com - February 5 at 3:22 PMUS biotech firm addresses critical gap in blood pressure managementmsn.com - December 27 at 8:55 PMShould we pay people for donating blood?bbc.com - December 20 at 1:36 PMA serial biotech company founder has Parkinson's. His latest company is targeting a potentially game-changing therapybizjournals.com - November 13 at 5:40 PMAmex GBT Sees More Small Companies Needing Business Travel Helpskift.com - November 8 at 12:06 PMGBT Technologies Cancels and Voids Reverse Stock Splitfinance.yahoo.com - November 8 at 7:06 AMGlobal Peripheral Blood Mononuclear Cells Research Report 2023: R&D Revolution - PBMCs Paving the Way for Medical Breakthroughsfinance.yahoo.com - October 6 at 6:48 PMDiabetes Prevalence Continues To Rise – Better Therapeutics' Digital Treatment Could Help Change This Trajectorybenzinga.com - September 28 at 9:01 AMPFE Mar 2024 32.500 callfinance.yahoo.com - July 28 at 4:25 PMGout Therapeutics Market Challenges, Drivers, Growth Opportunities, and Major Company Profiles 2023benzinga.com - June 17 at 3:10 PMGlobal Patient Blood Management Market to Reach $23.6 Billion by 2030finance.yahoo.com - June 14 at 1:07 PMGlobal Lymphoma Therapeutics Market Report 2023: Sector is Expected to Reach $24.9 Billion by 2029 at a CAGR of 7.8%finance.yahoo.com - June 12 at 3:35 PMGlobal Health Study Validates Biospectal OptiBP Mobile Blood Pressure Measurement App Accuracy Across Diverse Settingsfinance.yahoo.com - June 11 at 10:28 AMTed Love, now the chair of biotech's big trade group, talks drug access, leadership and 'crazy' co-paysbizjournals.com - June 7 at 12:35 PMGBT Received a Notice of Allowance for its Microchip Reliability Verification and Auto-Correction Patent Applicationfinance.yahoo.com - June 6 at 8:57 AMThe Global Non-insulin Diabetes Therapeutics Marketes-us.finanzas.yahoo.com - June 4 at 3:16 PMPfizer Announces $5.4 Billion Deal to Acquire Global Blood Therapeuticsmsn.com - May 23 at 12:40 PM(2023-2030) Anemia Drugs Market Size, Share and Trend Analysis Report, Worldwide Opportunities, Demand Forecastmarketwatch.com - May 17 at 12:55 PMArtificial Blood Market, Global Outlook and Forecast 2023-2029marketwatch.com - May 11 at 12:22 PM2030 Blood Cancer Therapeutics Market Forecast: Positive Growth Trajectory Aheadmarketwatch.com - May 5 at 8:01 PMRare Disease Therapeutics Global Market Report 2023: Increasing Number of Patients with Rare Diseases Bolsters Growthfinance.yahoo.com - May 5 at 3:01 PMMonoclonal Antibody Therapeutics Market to Surpass US$ 534.26 Billion by 2030, Says Coherent Market Insights (CMI)finance.yahoo.com - May 5 at 3:01 PMMetabolic Disorder Therapeutics Market 2023 Set to Growth Highest CAGR and Revenue by 2030marketwatch.com - May 5 at 10:01 AMGlobal Antimicrobial Therapeutics Market Report 2023-2027: Sector to Grow by $51.4 Billion at a 5.63% CAGRfinance.yahoo.com - May 4 at 1:08 AMProstate Cancer Therapeutics Global Market Report 2023: Launch of Emerging Novel Therapies Brings Momentumfinance.yahoo.com - April 27 at 10:21 AMGBT IP Technology Portfolio and Other Updatesfinance.yahoo.com - April 25 at 10:02 AMGBT's intelligent, human vitals qTerm device patent received an issue notificationtechnews.tmcnet.com - April 20 at 7:58 AMGlycobiology: Global Markets for Diagnostics and Therapeuticsfinance.yahoo.com - April 19 at 8:13 PMGBT’s Database Management System, Continuation Patent Received Notice of Allowancefinance.yahoo.com - April 13 at 9:40 AMGlobal Genetic Disorders Partnering 2023: Trends, Financials and Players from Every Deal Since 2016finance.yahoo.com - April 9 at 8:35 PM2023-2028 Anemia Drugs Market: Growth Investments and Opportunities by Top Playersmarketwatch.com - March 21 at 9:46 AMGBT Filed Patent Continuation Application for its Automatic Correction of Integrated Circuits Connectivity Mismatches Patenttmcnet.com - March 21 at 9:46 AMGlobal Acquired Orphan Blood Diseases Therapeutics Market Outlook and Major Regions’ Development Status By VMReportsmarketwatch.com - March 19 at 1:59 PMGlobal Breast Cancer Therapeutics Market to Reach $90.4 Billion by 2030finance.yahoo.com - March 17 at 8:04 PMGlobal Cystic Fibrosis Therapeutics Market to Reach $46.8 Billion by 2030finance.yahoo.com - March 17 at 10:03 AMGlobal Colorectal Cancer Therapeutics Market to Reach $22.3 Billion by 2030finance.yahoo.com - March 17 at 10:03 AM2023-2029 Anemia Drugs Market Size, Growth and Emerging Trend Analysis | Research Report by Absolute Reportsmarketwatch.com - March 15 at 3:09 PMGBT Filed a Trademark Application For Avant! AI Technologyfinance.yahoo.com - March 14 at 8:06 AMGlobal Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market to Reach $51.9 Billion by 2030finance.yahoo.com - March 11 at 7:35 AMGlobal Sepsis Therapeutics Market to Reach $433.2 Billion by 2030finance.yahoo.com - March 7 at 12:35 AMThe Global Blood Collection Devices Market to Register Incremental Growth at a CAGR of ~7% by 2027 | DelveInsightbenzinga.com - March 1 at 8:36 AMGBT, through its partially owned subsidiary, is Seeking to Enhance its Avant! AI Technology to Enable Robust and User-Friendly Experiencefinance.yahoo.com - February 28 at 9:49 AMBlood Cancer Drugs Global Market Report 2023finance.yahoo.com - February 25 at 7:53 AMAntisense & RNAi Therapeutics Global Market Report 2023yahoo.com - February 22 at 5:55 PMThe Rise of Anemia Drugs Market Research 2023-2027: Opportunities and Challenges with Top Countries Datamarketwatch.com - February 22 at 5:55 PMBlood And Blood Components Global Market Report 2023yahoo.com - February 20 at 9:31 PMAnemia Drugs Market 2023 Key Trends, Applications & Future Developments to 2028marketwatch.com - February 20 at 11:30 AMGlobal Melanoma Therapeutics Market to Reach $9.5 Billion by 2030finance.yahoo.com - February 17 at 5:52 PM Get Global Blood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GBT and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. GBT Media Mentions By Week GBT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBT News Sentiment▼0.520.42▲Average Medical News Sentiment GBT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBT Articles This Week▼00▲GBT Articles Average Week Get Global Blood Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Madrigal Pharmaceuticals News Today Organon & Co. News Today BridgeBio Pharma News Today Alpine Immune Sciences News Today Nuvalent News Today Perrigo News Today Alkermes News Today Blueprint Medicines News Today Insmed News Today CymaBay Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GBT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarningsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Blood Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
